STOCK TITAN
  1. Home
  2. APHB

APHB (APHB) Stock Price, News & Analysis

APHB

Company Description

This page collects what Stock Titan holds for APHB, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
—

Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

clinical trial
—

Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage

conferences
—

Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs

—

Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs

—

Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress

conferences
—

Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals

APHB has 9 recent news articles. Key topics include clinical trial, conferences, management. View all APHB news →

SEC Filings

View All

No SEC filings available for APHB.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months